This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.
A recent price hike of the drug Daraprim has a lot people taking a double look at the price we pay for medication.
A former hedge fund manager bought the drug and raised the price more than 700 percent.
That got a lot of people talking, and the company’s owner said he didn’t commit a crime. Which is true — the FDA has no authority over drug prices.
We’re talking with Dr. Rick Donlon, founder of Resurrection Health.
